1. Home
  2. ESQ vs IOVA Comparison

ESQ vs IOVA Comparison

Compare ESQ & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esquire Financial Holdings Inc.

ESQ

Esquire Financial Holdings Inc.

HOLD

Current Price

$104.32

Market Cap

858.2M

Sector

Finance

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.79

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESQ
IOVA
Founded
2006
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
858.2M
968.6M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
ESQ
IOVA
Price
$104.32
$2.79
Analyst Decision
Hold
Buy
Analyst Count
3
12
Target Price
$113.00
$10.45
AVG Volume (30 Days)
61.1K
11.3M
Earning Date
01-22-2026
11-06-2025
Dividend Yield
0.67%
N/A
EPS Growth
14.70
N/A
EPS
5.68
N/A
Revenue
$131,743,000.00
$250,425,000.00
Revenue This Year
N/A
$60.71
Revenue Next Year
$18.55
$59.52
P/E Ratio
$18.50
N/A
Revenue Growth
13.37
175.62
52 Week Low
$68.90
$1.64
52 Week High
$110.71
$8.15

Technical Indicators

Market Signals
Indicator
ESQ
IOVA
Relative Strength Index (RSI) 50.07 64.22
Support Level $105.38 $2.08
Resistance Level $107.88 $2.99
Average True Range (ATR) 2.64 0.17
MACD -0.41 0.06
Stochastic Oscillator 14.53 77.47

Price Performance

Historical Comparison
ESQ
IOVA

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: